Eli Lilly’s Obesity Pill Moves Closer to Approval August 26, 2025 John Cooper Global Market No comments yet **Eli Lilly’s Obesity Pill Shows Promising Results: What It Means for Investors** Eli Lilly & Co.’s experimental obesity pill has made headlines with… Read more
Eli Lilly’s obesity pill remains a viable rival to Novo’s oral Wegovy despite data that underwhelmed investors August 24, 2025 John Cooper Global Market No comments yet **Eli Lilly’s Orforglipron: A Game-Changer in the Diabetes Treatment market?** The diabetes treatment market is heating up, with pharmaceutical giant… Read more